Abstract: Benign anastomotic stricture is one of the most common complications after esophagectomy, which can result in the dysphagia and weight loss of patients. It can severely impair the patient′s quality of life with the progress of the stricture. What is more, refractory benign stricture is a major challenge for physicians and needs repeated treatments, which aggravates the patient′s pain and increases extra costs. Benign anastomotic stricture is associated closely with various risk factors, which can be prevented by adopting some measures. Dilation remains the firstline treatment to manage benign anastomotic stricture and it may be effective to combine with drug therapy. Endoscopic incisional therapy is a promising method as a new treatment therapy. The use of various stents fails to improve overall longterm dysphagiafree rate. In addition, stent has a possible risk of migration and hyperplastic tissue growth, which should be used by weighing the pros and cons.

Key words: Esophageal neoplasms, Deglutition disorders, Benign anastomotic stricture